Is now the right time to add Ansell to your portfolio?

The global trading environment remains challenging, but the recent price drop may be an opportunity.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At its Annual General Meeting yesterday, health device manufacturer and condom maker Ansell (ASX: ANN) said it is achieving moderate sales growth in the first quarter of FY 2014, but at a rate slightly lower than anticipated.

The company also maintained guidance that it expects to see earnings growth in the high single digits to low teens for the current financial year. In FY 2013 company earnings grew 11%.

On the external outlook, the group said subdued prices for commodities required to manufacture its products were a positive, alongside an expected renewal in growth in its North and Latin American markets.  On the downside labour and utility cost inflation in SE Asia was expected to continue, while the European economy remained sluggish.

Last year the group completed four acquisitions and launched 48 new products. Future acquisitions remain part of its growth strategy and the company bought Korean glove maker Midas for $US41.1 million in September this year.

Earnings per share are also expected to be up in the region of 5-11% for FY 2014. In FY 2013 they were up 5% while the total dividend payout was up 7%. The company trades on a current dividend yield of just under 2% on today's prices. The stock has been down more than 3% as investors react to the news of lower than anticipated growth in the first quarter.

Foolish takeaway

Ansell's truly global footprint means it can help diversify an investor's portfolio away from the general health of the Australian economy. In fact it now reports and operates in US dollars and less than 6% of global sales come from Australia. Health and wellbeing spending remains in an upward trend globally and the company should continue to see moderate growth. The recent price drop may provide long-term investors a good entry point to a quality company.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Tom Richardson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »